261 related articles for article (PubMed ID: 31922228)
1. PLAG1 silencing promotes cell chemosensitivity in ovarian cancer via the IGF2 signaling pathway.
Huang W; Li BR; Feng H
Int J Mol Med; 2020 Mar; 45(3):703-714. PubMed ID: 31922228
[TBL] [Abstract][Full Text] [Related]
2. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor 2 silencing restores taxol sensitivity in drug resistant ovarian cancer.
Brouwer-Visser J; Lee J; McCullagh K; Cossio MJ; Wang Y; Huang GS
PLoS One; 2014; 9(6):e100165. PubMed ID: 24932685
[TBL] [Abstract][Full Text] [Related]
4. Pleomorphic adenoma gene1 in reproduction and implication for embryonic survival in cattle: a review.
D'Occhio MJ; Campanile G; Baruselli PS; Porto Neto LR; Hayes BJ; Snr AC; Fortes MRS
J Anim Sci; 2024 Jan; 102():. PubMed ID: 38586898
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Igf and Wnt signalling associated genes in pleomorphic adenomas of the salivary glands in PLAG1 transgenic mice.
Declercq J; Van Dyck F; Van Damme B; Van de Ven WJ
Int J Oncol; 2008 May; 32(5):1041-7. PubMed ID: 18425330
[TBL] [Abstract][Full Text] [Related]
6. MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R.
Zhang Y; Huang S; Guo Y; Li L
Biomed Pharmacother; 2018 Oct; 106():1357-1363. PubMed ID: 30119207
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer.
Huang GS; Brouwer-Visser J; Ramirez MJ; Kim CH; Hebert TM; Lin J; Arias-Pulido H; Qualls CR; Prossnitz ER; Goldberg GL; Smith HO; Horwitz SB
Clin Cancer Res; 2010 Jun; 16(11):2999-3010. PubMed ID: 20404007
[TBL] [Abstract][Full Text] [Related]
8. Cell type and context-specific function of PLAG1 for IGF2 P3 promoter activity.
Akhtar M; Holmgren C; Göndör A; Vesterlund M; Kanduri C; Larsson C; Ekström TJ
Int J Oncol; 2012 Dec; 41(6):1959-66. PubMed ID: 23023303
[TBL] [Abstract][Full Text] [Related]
9. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
Li H; Zhou Y; Cheng H; Tian J; Yang S
Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA let‑7d‑5p rescues ovarian cancer cell apoptosis and restores chemosensitivity by regulating the p53 signaling pathway via HMGA1.
Chen YN; Ren CC; Yang L; Nai MM; Xu YM; Zhang F; Liu Y
Int J Oncol; 2019 May; 54(5):1771-1784. PubMed ID: 30816441
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation-mediated repression of miR-181a/135a/302c expression promotes the microsatellite-unstable colorectal cancer development and 5-FU resistance via targeting PLAG1.
Shi L; Li X; Wu Z; Li X; Nie J; Guo M; Mei Q; Han W
J Genet Genomics; 2018 Apr; 45(4):205-214. PubMed ID: 29735329
[TBL] [Abstract][Full Text] [Related]
12. [Molecular techniques lead to the first insights into the pathophysiology of salivary gland adenomas].
Kas K
Verh K Acad Geneeskd Belg; 2001; 63(1):35-40. PubMed ID: 11284386
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells.
Wan J; Shi F; Xu Z; Zhao M
Int J Oncol; 2015 Dec; 47(6):2217-25. PubMed ID: 26498997
[TBL] [Abstract][Full Text] [Related]
14. Mutations in microRNA processing genes in Wilms tumors derepress the
Chen KS; Stroup EK; Budhipramono A; Rakheja D; Nichols-Vinueza D; Xu L; Stuart SH; Shukla AA; Fraire C; Mendell JT; Amatruda JF
Genes Dev; 2018 Aug; 32(15-16):996-1007. PubMed ID: 30026293
[TBL] [Abstract][Full Text] [Related]
15. miR-146b promotes cell proliferation and increases chemosensitivity, but attenuates cell migration and invasion via FBXL10 in ovarian cancer.
Yan M; Yang X; Shen R; Wu C; Wang H; Ye Q; Yang P; Zhang L; Chen M; Wan B; Zhang Q; Xia S; Lu X; Shao G; Zhou X; Yu J; Shao Q
Cell Death Dis; 2018 Nov; 9(11):1123. PubMed ID: 30409964
[TBL] [Abstract][Full Text] [Related]
16. Genetic disruption of the oncogenic HMGA2-PLAG1-IGF2 pathway causes fetal growth restriction.
Abi Habib W; Brioude F; Edouard T; Bennett JT; Lienhardt-Roussie A; Tixier F; Salem J; Yuen T; Azzi S; Le Bouc Y; Harbison MD; Netchine I
Genet Med; 2018 Feb; 20(2):250-258. PubMed ID: 28796236
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA Linc00312 modulates the sensitivity of ovarian cancer to cisplatin via the Bcl-2/Caspase-3 signaling pathway.
Zhang C; Wang M; Shi C; Shi F; Pei C
Biosci Trends; 2018 Jul; 12(3):309-316. PubMed ID: 29952351
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Eag1 Expression by RNA Interference Increases Chemosensitivity to Cisplatin in Ovarian Cancer Cells.
Hui C; Lan Z; Yue-li L; Li-lin H; Li-lin H
Reprod Sci; 2015 Dec; 22(12):1618-26. PubMed ID: 26079730
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA (hsa_circ_0051240) promotes cell proliferation, migration and invasion in ovarian cancer through miR-637/KLK4 axis.
Zhang M; Xia B; Xu Y; Zhang Y; Xu J; Lou G
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1224-1233. PubMed ID: 30945557
[TBL] [Abstract][Full Text] [Related]
20. NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer.
Chang H; Li B; Zhang X; Meng X
Biochem Biophys Res Commun; 2020 Feb; 522(2):292-299. PubMed ID: 31761329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
